Stratford A

Synex Synthetics BV, Maastricht, The Netherlands.

13 papers

ArticleLSD

Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).

Brandt SD, Kavanagh PV, Gare S +3

Europe PMC2025
ArticleLSD

Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD).

Brandt SD, Kavanagh PV, Gare S +2

Europe PMC2025
ArticleLSD

Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD).

Kavanagh PV, Westphal F, Pulver B +4

Europe PMC2025
ArticleLSD

Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N<sup>6</sup> -ethylnorlysergic acid N,N-diethylamide (ETH-LAD).

Brandt SD, Kavanagh PV, Westphal F +5

Europe PMC2024
ArticleLSD

Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities.

Kavanagh PV, Westphal F, Pulver B +6

Europe PMC2023
ArticlePsilocybin

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.

Brandt SD, Kavanagh PV, Westphal F +6

Europe PMC2022
ArticleLSD

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD).

Brandt SD, Kavanagh PV, Westphal F +5

Europe PMC2022
ArticleLSD

Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ).

Brandt SD, Kavanagh PV, Westphal F +4

Europe PMC2020
ArticleLSD

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).

Brandt SD, Kavanagh PV, Westphal F +8

Europe PMC2020
ArticleLSD

Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).

Halberstadt AL, Chatha M, Klein AK +5

Europe PMC2020
ArticleLSD

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Brandt SD, Kavanagh PV, Westphal F +5

Europe PMC2019
ArticleLSD

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Halberstadt AL, Klein LM, Chatha M +5

Europe PMC2019
ArticleLSD

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

Brandt SD, Kavanagh PV, Twamley B +8

Europe PMC2018